Renaissance Insurance Group JSC (MOEX: RENI)
Russia
· Delayed Price · Currency is RUB
47.25
-0.19 (-0.40%)
At close: Jul 8, 2022
RENI Income Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2016 |
Premiums & Annuity Revenue | 138,464 | 116,974 | 96,799 | 80,492 | 74,012 | 71,733 | Upgrade
|
Total Interest & Dividend Income | 12,585 | 19,096 | 9,063 | 7,911 | 7,418 | 3,845 | Upgrade
|
Total Revenue | 151,049 | 136,069 | 105,862 | 88,403 | 81,430 | 75,578 | Upgrade
|
Revenue Growth (YoY) | 45.86% | 28.53% | 19.75% | 8.56% | 7.74% | 81.67% | Upgrade
|
Policy Benefits | 88,087 | 78,710 | 50,452 | 46,023 | 43,096 | 34,618 | Upgrade
|
Policy Acquisition & Underwriting Costs | 38,475 | 33,839 | 42,480 | 29,713 | 24,802 | 29,242 | Upgrade
|
Amortization of Goodwill & Intangibles | - | - | - | 43.71 | 222.46 | 246.49 | Upgrade
|
Selling, General & Administrative | 12,145 | 9,879 | 7,828 | 6,636 | 6,505 | 6,316 | Upgrade
|
Provision for Bad Debts | 849.58 | 1,344 | 125.54 | 123.4 | 192.34 | 190.87 | Upgrade
|
Other Operating Expenses | 2,083 | 2,565 | 1,332 | 1,145 | 830.41 | 1,113 | Upgrade
|
Total Operating Expenses | 141,639 | 126,337 | 102,218 | 83,685 | 75,648 | 71,726 | Upgrade
|
Operating Income | 9,410 | 9,733 | 3,645 | 4,719 | 5,782 | 3,852 | Upgrade
|
Interest Expense | -271.77 | -218.05 | -463.05 | -366.54 | -337.32 | -333.39 | Upgrade
|
Earnings From Equity Investments | -39.71 | -134.22 | - | - | - | - | Upgrade
|
Currency Exchange Gain (Loss) | -125.06 | 3,527 | 20.8 | 767.67 | -220.37 | 293.81 | Upgrade
|
Other Non Operating Income (Expenses) | - | - | 262.96 | 353.11 | - | 376.05 | Upgrade
|
EBT Excluding Unusual Items | 8,973 | 12,908 | 3,466 | 5,473 | 5,224 | 4,189 | Upgrade
|
Gain (Loss) on Sale of Assets | 46.09 | 196.21 | - | - | - | - | Upgrade
|
Pretax Income | 9,019 | 13,104 | 3,466 | 5,473 | 5,224 | 4,189 | Upgrade
|
Income Tax Expense | 1,834 | 2,776 | 299.86 | 1,028 | 1,077 | 811.04 | Upgrade
|
Earnings From Continuing Ops. | 7,186 | 10,328 | 3,166 | 4,445 | 4,147 | 3,378 | Upgrade
|
Earnings From Discontinued Ops. | - | - | 425.19 | 234.91 | - | - | Upgrade
|
Net Income | 7,186 | 10,328 | 3,591 | 4,680 | 4,147 | 3,378 | Upgrade
|
Net Income to Common | 7,186 | 10,328 | 3,591 | 4,680 | 4,147 | 3,378 | Upgrade
|
Net Income Growth | 83.59% | 187.61% | -23.26% | 12.84% | 22.78% | 145.94% | Upgrade
|
Shares Outstanding (Basic) | 523 | 537 | 445 | 410 | 410 | 410 | Upgrade
|
Shares Outstanding (Diluted) | 523 | 537 | 445 | 410 | 410 | 410 | Upgrade
|
Shares Change (YoY) | 22.28% | 20.62% | 8.64% | -0.00% | - | - | Upgrade
|
EPS (Basic) | 13.75 | 19.24 | 8.07 | 11.42 | 10.12 | 8.24 | Upgrade
|
EPS (Diluted) | 13.75 | 19.24 | 8.07 | 11.42 | 10.12 | 8.24 | Upgrade
|
EPS Growth | 50.14% | 138.44% | -29.37% | 12.85% | 22.78% | - | Upgrade
|
Free Cash Flow | 19,975 | 15,371 | -11,169 | 3,071 | 8,606 | -647.55 | Upgrade
|
Free Cash Flow Per Share | 38.22 | 28.63 | -25.10 | 7.49 | 21.01 | -1.58 | Upgrade
|
Dividend Per Share | 2.300 | 10.000 | - | - | - | - | Upgrade
|
Operating Margin | 6.23% | 7.15% | 3.44% | 5.34% | 7.10% | 5.10% | Upgrade
|
Profit Margin | 4.76% | 7.59% | 3.39% | 5.29% | 5.09% | 4.47% | Upgrade
|
Free Cash Flow Margin | 13.22% | 11.30% | -10.55% | 3.47% | 10.57% | -0.86% | Upgrade
|
EBITDA | - | 10,026 | 3,871 | 4,930 | 5,983 | 4,010 | Upgrade
|
EBITDA Margin | - | 7.37% | 3.66% | 5.58% | 7.35% | 5.31% | Upgrade
|
D&A For EBITDA | - | 293.62 | 225.71 | 211.38 | 201.35 | 157.93 | Upgrade
|
EBIT | 9,410 | 9,733 | 3,645 | 4,719 | 5,782 | 3,852 | Upgrade
|
EBIT Margin | 6.23% | 7.15% | 3.44% | 5.34% | 7.10% | 5.10% | Upgrade
|
Effective Tax Rate | 20.33% | 21.19% | 8.65% | 18.79% | 20.62% | 19.36% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.